Haematopoietic stem cell transplant (HCT) and cellular therapy (CT) recipients are profoundly immunocompromised and susceptible to vaccine-preventable infections. Although major societies have published post-HCT vaccination guidelines [1,2,3], consensus and adherence are not universal. CT use is expanding, but vaccination recommendations are not clearly established, and data on late infections and long-term effects remain unclear [4].
Benjamin Teh
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Benjamin
Contact Benjamin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack